Whitehawk Therapeutics (WHWK) Retained Earnings: 2018-2025
Historic Retained Earnings for Whitehawk Therapeutics (WHWK) over the last 8 years, with Sep 2025 value amounting to -$330.0 million.
- Whitehawk Therapeutics' Retained Earnings fell 4.96% to -$330.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$330.0 million, marking a year-over-year decrease of 4.96%. This contributed to the annual value of -$332.7 million for FY2024, which is 23.68% down from last year.
- According to the latest figures from Q3 2025, Whitehawk Therapeutics' Retained Earnings is -$330.0 million, which was down 5.67% from -$312.3 million recorded in Q2 2025.
- Whitehawk Therapeutics' Retained Earnings' 5-year high stood at -$126.7 million during Q3 2021, with a 5-year trough of -$332.7 million in Q4 2024.
- Over the past 3 years, Whitehawk Therapeutics' median Retained Earnings value was -$287.3 million (recorded in 2024), while the average stood at -$283.1 million.
- Data for Whitehawk Therapeutics' Retained Earnings shows a peak YoY increase of 10.67% (in 2021) and a maximum YoY decrease of 337.75% (in 2021) over the last 5 years.
- Over the past 5 years, Whitehawk Therapeutics' Retained Earnings (Quarterly) stood at -$142.7 million in 2021, then tumbled by 42.41% to -$203.2 million in 2022, then slumped by 32.36% to -$269.0 million in 2023, then dropped by 23.68% to -$332.7 million in 2024, then fell by 4.96% to -$330.0 million in 2025.
- Its Retained Earnings was -$330.0 million in Q3 2025, compared to -$312.3 million in Q2 2025 and -$259.6 million in Q1 2025.